access to experimental potentially life-saving cancer treatments could get easier thanks to a new government review of the process our kxan investigation started last summer when we told you about austin advocate andrea sloan's struggle to get an experimental ovarian cancer drug her fight highlighted problems with the compassionate use system after being denied a drug by a pharmaceutical company sloan died in january in november i traveled to washington d.c to find out what congress was going to do to fix the system congressman michael mccall told us he was working to reform the system and today the u.s house appropriations committee recommended a review of how the fda is working to accelerate the approval of safe and effective medicines mccall said in part today it is a significant first step in finding ways to make treatments more widely available